Aditya Birla Capital Ltd Q2 2021 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Nidhesh Jain - Investec Bank plc, Research Division - Analyst : Sir, if I look at the COVID provisions on NBFC, that is on the INR 139 crores cumulative and COVID provisions on housing finance is INR 30 crores cumulative. Are these the right numbers?

Question: Nidhesh Jain - Investec Bank plc, Research Division - Analyst : Sir, how do we see the adequacy of these provisions going forward? Do we expect more provisions to be created in these 2 books? And if you give some data around what percentage of our loan book has not paid any installment in the month of September or October so that can give us some indication of the COVID-related credit costs which will come in future, and then we can compare that with your provisions, whether the provisions are adequate or not? That should be somewhat helpful.

Question: Nidhesh Jain - Investec Bank plc, Research Division - Analyst : And what would be the credit cost guidance for Housing Finance Company for H2? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. NOVEMBER 05, 2020 / 12:00PM, ADTB.NS - Q2 2021 Aditya Birla Capital Ltd Earnings Call

Question: Nidhesh Jain - Investec Bank plc, Research Division - Analyst : Got it. And how are we looking at loan growth in H2? I think you guided that there will be a 5% growth in H2 in NBFC. That 5% is on September base?

Question: Nidhesh Jain - Investec Bank plc, Research Division - Analyst : And is it similar -- I mean, any indication on the housing finance book?

Question: Nidhesh Jain - Investec Bank plc, Research Division - Analyst : Sure, sir. And moving to the life insurance, there, I've seen that there has been a sharp increase in the non-PAR products in our mix. So despite that, our gross margins have not moved up. I see that the share of PAR has come down and share of non-PAR has gone up. So what is the reason for that?

Question: Nidhesh Jain - Investec Bank plc, Research Division - Analyst : And then lastly, on the health insurance, do we see any tail risk of the COVID claims coming in Q3 or Q4? Because I think in H1, we have some -- we have got some benefit of -- on COVID-related claims, but how do we see that panning out in H2?

Question: Nidhesh Jain - Investec Bank plc, Research Division - Analyst : Sir, can you share the quantum of disbursement, if any, we have done under credit guarantee scheme in the NBFC and housing plans?